Application 213551

Type: ANDA
Sponsor: GLAND PHARMA LTD

Application Products#

Product, Drug, Ingredient table
Product	Drug	Ingredient	Form	Strength	Reference drug	Reference standard
001	CANGRELOR	CANGRELOR	POWDER;INTRAVENOUS	50MG/VIAL	No	No

Source provenance: Browse the complete Orange Book source catalog · source snapshot 42.

Orange Book products#

Current product rows page 1 of 1 · 1 matching rows.

Application-product, Trade name, Ingredient table
Application-product	Trade name	Ingredient	Strength	Dosage form / route	TE codes	RLD / RS	Approval date
A213551-001	CANGRELOR	CANGRELOR	50MG/VIAL	POWDER / INTRAVENOUS	AP		2025-08-11

Therapeutic equivalence codes#

Current TE-code rows page 1 of 1 · 1 matching rows.

Application-product, TE code table
Application-product	TE code
A213551-001	AP

Observed Orange Book product history#

Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.

Captured, Edition, Application-product table
Captured	Edition	Application-product	Trade name	Strength	Dosage form / route	Product TE source text	Approval date	Source SHA-256
2026-08-18 06:07:40	2026-07	A213551-001	CANGRELOR	50MG/VIAL	POWDER / INTRAVENOUS	AP	2025-08-11	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A213551-001	CANGRELOR	50MG/VIAL	POWDER / INTRAVENOUS	AP	2025-08-11	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A213551-001	CANGRELOR	50MG/VIAL	POWDER / INTRAVENOUS	AP	2025-08-11	`31067a03dcf5…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A213551-001	CANGRELOR	50MG/VIAL	POWDER / INTRAVENOUS	AP	2025-08-11	`a50c72e98297…`

Observed Orange Book normalized TE history#

Captured, Edition, Application-product table
Captured	Edition	Application-product	TE code	Order	Source SHA-256
2026-08-18 06:07:40	2026-07	A213551-001	AP	1	`caaa826d4ba7…`
2026-02-19 14:30 UTC	2026-02	A213551-001	AP	1	`011fe1cb6892…`
2025-12-14 10:44 UTC · 2 captures of this ZIP	2025-12	A213551-001	AP	1	`31067a03dcf5…`
2026-07-26 02:55 UTC · 3 captures of this ZIP	2026-06	A213551-001	AP	1	`a50c72e98297…`

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
Brand	Generic	Manufacturer	SPL set ID	Effective date	Available safety fields	Join
Cangrelor	CANGRELOR	Gland Pharma Limited	c86264c2-ef49-4524-b6af-edb7a6279faa	2025-08-14	Warnings, Adverse reactions	Exact identifier application applno (ANDA): 213551 application number: ANDA213551

Documents#

Document, Submission type, Date table
Document	Submission type	Date
69855	ORIG	2022-01-12